Ann: EVT801 preclinical data published, page-46

All valid points @plough no shrines here the last being blown up back in 2015-16. The criticism is valid the question is how do they let the sp recover and in my mind that means a 100% stop to fund raising ie issuing more shares which should have been done some time ago when it was obvious it was killing the sp but it seems they were either deliberate in diluting or they were desperate.. They need to revisit everything simply printing shares is woeful in the extreme and its not like the company in its Novogen form didn't already know this..

When the market knows your desperate its a tough sell to portray sunshine at the end of the tunnel and enough of us here bought and held on through a very long tunnel already!

Get it together Kazia